相关实验视频

Updated: May 15, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

通过量身定制的纳米反应器抑制缺氧-腺协同轴,用于增强光热免疫治疗

Jingjing Gu¹, Jiao Chang², Shiyu Chen¹

¹Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration Ministry of Education Tongji Hospital The Institute for Biomedical Engineering & Nano Science School of Medicine Tongji University Shanghai 200092 P. R. China.

|April 11, 2025

概括

这项研究引入了PM@Mn纳米颗粒,以减少瘤中的免疫抑制性腺. 这种策略通过准缺氧-腺协同轴,增强T细胞透和瘤抑制来增强抗瘤免疫力.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
癌症治疗癌症治疗

背景情况:

由于缺氧导致的腺素积累,通过向免疫细胞来抑制抗瘤免疫力.
缺氧-腺协同轴通过在免疫细胞死亡 (ICD) 期间释放的免疫激活腺三酸盐 (ATP) 的代谢来加剧腺的积累.
目前的策略,如腺清除或受体阻塞有局限性.

研究的目的:

开发一种创新的纳米医学策略,以调节上游的低氧/HIF-1α信号通路.
为了降低细胞外腺水平并增强ICD触发的抗瘤免疫力.
在小鼠乳腺癌模型中研究PM@Mn纳米颗粒的疗效.

主要方法:

通过在聚多巴胺 (PDA) 上集成甲胺和MnO2来构建PM@Mn纳米粒子.
PM@Mn利用催化氧气生产和减少氧气消耗来缓解瘤缺氧.
评估PM@Mn对缺氧-腺协同轴,ATP代谢,HIF-1α,CD39,CD73表达和ICD诱导的影响.

主要成果:

PM@Mn有效地抑制了缺氧-腺协同轴,减少了腺的积累.
低氧缓解导致HIF-1α,CD39和CD73的下调,抑制ATP对腺代谢的发生.
在一个低免疫性小鼠乳腺癌模型中,PM@Mn使细胞毒性T淋巴细胞的透率增加了4.51倍,并实现了75.4%的瘤抑制率.

结论:

这项研究提出了一种新的策略,通过准缺氧-腺协同轴来对抗瘤免疫抑制.
PM@Mn纳米粒子提供了一种有希望的方法来增强ICD触发的抗瘤免疫力.
这项工作通过调节瘤微环境,为癌症免疫治疗提供了新的途径.

关键词:

亚地诺协同轴的作用.减轻低氧的缓解作用免疫性细胞死亡免疫性细胞死亡免疫抑制是一种免疫抑制.光热免疫疗法光热免疫疗法

更多相关视频

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.